Diasorin Logo

Diasorin

Develops immunodiagnostic and molecular diagnostic kits and systems for healthcare and research.

DIA | XMIL

Overview

Corporate Details

ISIN(s):
IT0003492391 (+2 more)
LEI:
8156002878BDF0EE4348
Country:
Italy
Address:
VIA CRESCENTINO, SNC, 13040 SALUGGIA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Diasorin is a global leader in the in vitro diagnostics (IVD) market, specializing in the development, manufacturing, and commercialization of reagent kits and automated systems. The company's core focus is on two primary segments: immunodiagnostics and molecular diagnostics. In immunodiagnostics, Diasorin provides advanced solutions, including its LIAISON® family of analyzers, which detect antibodies and antigens to aid in the diagnosis of diseases. Its molecular diagnostics division offers flexible tools that use targeted and multiplex technologies to identify pathogens in biological specimens, providing healthcare providers with critical, actionable information. The company also operates in the Licensed Technology sector, offering platforms for biomedical research, clinical diagnostics, and drug discovery to help scientists find rapid and reliable answers to complex biological questions.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-07 10:03
Regulatory News Service
Communication on total amount of voting rights
Italian 229.7 KB
2025-10-07 10:01
Regulatory News Service
Comunicazione dell'ammontare complessivo dei diritti di voto
Italian 210.3 KB
2025-09-05 10:34
Declaration of Voting Results & Voting Rights Announcements
Communication on total amount of voting rights
English 206.3 KB
2025-09-05 10:32
Declaration of Voting Results & Voting Rights Announcements
Comunicazione dell'ammontare complessivo dei diritti di voto
Italian 209.6 KB
2025-08-07 11:29
Interim Report
Interim Financial Report as at June 30, 2025
English 3.0 MB
2025-08-04 16:51
Report Publication Announcement
Pubblicazione della Relazione finanziaria semestrale al 30 giugno 2025
Italian 184.4 KB
2025-08-04 15:32
Interim Report
Relazione Finanziaria Semestrale del Gruppo Diasorin al 30 giugno 2025
Italian 3.4 MB
2025-07-31 16:24
Investor Presentation
Diasorin H1 2025 Results Presentation
English 1.4 MB
2025-07-31 16:22
Earnings Release
Revenue Growth and Margin Expansion in H1 2025. FY 2025 Guidance Confirmed
English 342.3 KB
2025-07-31 16:21
Earnings Release
Ricavi in crescita ed incremento della marginalità nel 1° semestre 2025. Confer…
Italian 470.4 KB
2025-07-07 09:34
Declaration of Voting Results & Voting Rights Announcements
Communication on total amount of voting rights
English 210.5 KB
2025-07-07 09:32
Declaration of Voting Results & Voting Rights Announcements
Comunicazione dell'ammontare complessivo dei diritti di voto
Italian 232.4 KB
2025-07-01 08:57
Transaction in Own Shares
Diasorin S.p.A. - Allegato 3F
Italian 91.4 KB
2025-05-12 15:37
Post-Annual General Meeting Information
Pubbicazione del verbale dell'Assemblea degli Azionisti del 28 aprile 2025
Italian 184.1 KB
2025-05-12 15:26
Post-Annual General Meeting Information
Verbale Assemblea Ordinaria degli Azionisti 28 aprile 2025
English 21.1 MB

Automate Your Workflow. Get a real-time feed of all Diasorin filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Diasorin via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea 397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea 003060
Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea 007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea 293780

Talk to a Data Expert

Have a question? We'll get back to you promptly.